Status:
COMPLETED
Genetics of COVID-19 Susceptibility and Manifestations
Lead Sponsor:
National Human Genome Research Institute (NHGRI)
Conditions:
COVID-19
Coronavirus 2019
Eligibility:
All Genders
1-110 years
Brief Summary
Background: Coronavirus 2019 (COVID-19, or SARS-CoV-2) is a serious public health problem, and genetics may play a role in how serious the illness becomes in certain people. Genes are the instruction...
Detailed Description
The current SARS-CoV-2 pandemic presents a serious challenge to public health. Individuals infected with SARS-CoV-2 experience extremes in symptomatology ranging from a complete lack of symptoms to ra...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA
- Cohort 1 (Existing NIH Clinical Center Patient/Participants invited to participate by their NIH study team)
- Cohort 2 (Individuals recruited through NIH Occupational Medicine Services (OMS) patients referred by NIH investigators or other providers; individuals who self-refer)
- Located in the United States
- Positive test for SARS-CoV-2 virus infection
- Age greater than or equal to 3 years old
- only for participants providing a blood sample
- EXCLUSION CRITERIA:
- Individuals for whom we cannot consent for participation in a language offered by our existing interpretation service.
- Weight less than 10 kg\*
Exclusion
Key Trial Info
Start Date :
May 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2024
Estimated Enrollment :
721 Patients enrolled
Trial Details
Trial ID
NCT04371432
Start Date
May 5 2020
End Date
December 15 2024
Last Update
December 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892